Indication-based pricing of the pharmaceuticals in Croatia: case-study
Authors
- Vanesa Benković (ORCID: https://orcid.org/0000-0003-0399-8008)
- Elizabeta Ribarić (ORCID: https://orcid.org/0000-0001-5872-7139)
- Luka Vončina (ORCID: https://orcid.org/0000-0002-1864-2381)
- Ana Bobinac (ORCID: https://orcid.org/0000-0001-8798-9795)
- Ismar Velić (ORCID: https://orcid.org/0000-0003-3478-9014)
Institutions
- University of Rijeka (HR)
- University of Zagreb (HR)
- Novo Nordisk (United Kingdom) (GB)
Publication Details
- Journal
- Expert Review of Pharmacoeconomics & Outcomes Research
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1080/14737167.2025.2478232
- Citations
- 1
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 3.13